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Abstract
Background: Autonomic dysreflexia is a severe and potentially life-threatening condition in patients with spinal
cord injury, as it can lead to myocardial ischemia, brain hemorrhage, or even death. Urodynamic investigation is the
gold standard to assess neurogenic lower urinary tract dysfunction due to spinal cord injury and reveal crucial
pathological findings, such as neurogenic detrusor overactivity. However, neurogenic detrusor overactivity and
urodynamic investigation are known to be leading triggers of autonomic dysreflexia. Therefore, we aimed to
determine predictors of autonomic dysreflexia in individuals with spinal cord injury during urodynamic
investigation.
Methods: This prospective cohort study included 300 patients with spinal cord injuries and complete datasets of
continuous non-invasive cardiovascular monitoring, recorded during same session repeat urodynamic investigation.
We used logistic regression to reveal predictors of autonomic dysreflexia during urodynamic investigation.
Results: We found that level of injury and presence of neurogenic detrusor overactivity were the only two
independent significant predictors for autonomic dysreflexia during urodynamic investigation. A lesion at
spinal segment T6 or above (odds ratio (OR) 5.5, 95% CI 3.2–9.4) compared to one at T7 or below, and
presence of neurogenic detrusor overactivity (OR 2.7, 95% confidence interval (CI) 1.4–4.9) were associated
with a significant increased odds of autonomic dysreflexia during urodynamic investigation. Both odds
persisted after adjustment for age, sex, and completeness and stage of injury (adjusted OR (AOR) 6.6, 95% CI
3.8–11.7, and AOR 2.2, 95% CI 1.1–4.5, respectively). Further stratification by lesion level showed level-
dependent significantly increased adjusted odds of autonomic dysreflexia, i.e., from C1–C4 (AOR 16.2, 95% CI
5.9–57.9) to T4–T6 (AOR 2.6, 95% CI 1.3–5.2), compared to lesions at T7 or below.
Conclusions: In patients with neurogenic lower urinary tract dysfunction due to spinal cord injury, autonomic
dysreflexia is independently predicted by lesion level and presence of neurogenic detrusor overactivity.
Considering the health risks associated with autonomic dysreflexia, such as seizures, stroke, retinal bleeding, or
even death, we recommend both continuous cardiovascular monitoring during urodynamic investigation in all
spinal cord-injured patients with emphasis on those with cervical lesions, and appropriate neurogenic detrusor
overactivity treatment to reduce the probability of potentially life-threatening complications.
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Background
Spinal cord injury (SCI), a devastating event [1], is ac-
quired by almost half a million people each year world-
wide [2]. Besides motor recovery, i.e., the ability to walk or
utilize the upper extremities, lower urinary tract (LUT) [3,
4] and cardiovascular system (CVS) [5] function are
among the primary priorities for patients with SCI [6].
Autonomic dysreflexia (AD) [7], a severe, potentially life-
threatening condition affecting the CVS following SCI
that can occur more than 40 times a day [8], is elicited by
either noxious (e.g., pain) and innocuous stimuli (e.g.,
bladder filling) from below the level of injury [9]. If mis-
diagnosed or poorly managed, AD can result in disastrous
consequences [10], including myocardial ischemia [11],
brain hemorrhage [12], seizures [13], and even death [14].
Urodynamic investigation (UDI) is the gold standard
to assess neurogenic lower urinary tract dysfunction
(NLUTD) in patients with SCI [3, 4], but it may induce
AD [15, 16]. Considering that it is currently not possible
to know in advance which patient will experience AD
during UDI and, of those with AD, to what extent the
systolic blood pressure (SBP) will increase, we aimed to
determine the overall incidence and predictors of AD
during UDI.
Methods
Participants and study design
This prospective cohort study was conducted at a single
university SCI center between January 2011 and December
2016. Inclusion criteria were patients with NLUTD due to
suprasacral SCI and age of at least 18 years. Exclusion cri-
teria were symptomatic urinary tract infections (i.e., positive
urine culture and clinical symptoms including fever), pres-
sure ulcers at the time of UDI, and incomplete data of
cardiovascular monitoring (CVM) during UDI. Overall, 300
patients (41 females and 259 males, mean age 51 ± 16 years,
mean duration since SCI 10 ± 12 years) with complete car-
diovascular recordings were included for analysis. The pa-
tients’ characteristics are shown in Table 1. This study was
approved by the local ethics committee and is registered at
ClinicalTrials.gov (NCT01293110). All patients gave written
informed consent according to the Helsinki II declaration.
Predictor variables and outcomes
The neurological level and completeness of SCI, i.e.,
sensorimotor impairment, were determined using the
American Spinal Injury Association Impairment Scale
(AIS) according to the International Standards for Neuro-
logical Classification of Spinal Cord Injury (ISNCSCI)
[17]. The stage of injury was classified as acute (less than
300 days since injury) and chronic (more than 300 days
since injury), in accordance with the European Multicenter
Study about Spinal Cord Injury (EMSCI, www.emsci.org)
definition.
All methods, definitions, and units are in line with the
standards recommended by the International Continence
Society (ICS) [18, 19]. All patients were asked to empty
their bladder and bowels prior to the UDI, which was per-
formed according to Good Urodynamic Practice following
the recommendations of the ICS [18].
Individuals were investigated in a sitting position,
whenever possible, which reflects the position of an indi-
vidual with SCI when emptying the bladder, e.g., using
intermittent self-catheterization, while sitting in a wheel-
chair or on a toilet. A 7 French transurethral latex-free
single-use catheter and a common rectal catheter for
simultaneous measurements of vesical and abdominal
pressure were used. Since rectal manipulation itself can
elicit AD [20], UDI was only initiated in the absence of
AD. The bladder was filled retrograde with a 37°C mix-
ture of 0.9% sodium chloride solution and contrast
medium.
All patients underwent same session repeat UDI [21],
i.e., two consecutive measurements, using a multichan-
nel urodynamic system (Sedia®, Givisiez, Switzerland).
Continuous cardiovascular monitoring (Finometer® PRO,
Finapres Medical Systems (FMS), Amsterdam, The
Netherlands) [22] was applied to enable a non-stop
“beat-to-beat” documentation of SBP, diastolic BP (DBP),
and heart rate (HR) synchronous to the ongoing UDI.
AD (the primary outcome) was defined according to the
International Standards to document remaining Auto-
nomic Function after SCI (ISAFSCI) as an increase in
SBP ≥ 20 mmHg from baseline [23]. In case of clinical
signs of AD such as headache, flushing, sweating, and
piloerection [24, 25], UDI was stopped immediately and
the bladder was emptied.
Statistical analysis
Continuous variables including age, time since injury,
SBP, DBP, and HR were visually inspected for normal
distribution by using Q-Q plots. Normally distributed
data were analyzed using analysis of variance (ANOVA)
or unpaired t tests to compare between groups. Results
are presented as mean ± standard deviation (SD) or 95%
confidence intervals (CIs), respectively. The k statistic
was used to investigate agreement of the presence or ab-
sence of AD between the two UDI sessions. A chi-
square test or Fisher’s exact test were used to assess the
relationship between categorical variables.
Logistic regression (bivariable and multivariable) was
used to investigate predictors of AD during UDI. Un-
adjusted odds ratios (ORs) and adjusted odds ratios
(AORs) are presented with corresponding 95% CI. Stat-
istical significance was defined as a p value of less than
0.05. Statistical analyses were performed using R Studio
version 1.0.136 (Integrated Development for R, RStudio,
Inc., Boston, MA, USA).
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Results
Overall incidence and repeatability of autonomic
dysreflexia during urodynamic investigation
The overall incidence of AD during UDI was 68%
(204/300). AD was found in 176 (59%) vs. 162 (54%)
of the 300 patients during the first and the second
UDI, respectively. In 66% (134/204) of patients with
AD, an increase in SBP of at least 20 mmHg was elic-
ited during both UDIs. Hence, in more than one third
of all patients with AD (70/204), bladder filling elicited
AD in only one of two UDIs. The repeatability of de-
tecting AD between the two same session UDIs was
moderate (k = 0.53, 95% CI –0.4 to 1.5). Characteristics of
clinical symptoms presented by 37% (75/204) of pa-
tients with AD during UDI are shown in Fig. 1. We
did not observe any imminent complication as a re-
sult of the increase in SBP associated with AD during
UDI. All patients were monitored until SBP returned
to baseline values and, whenever present, clinical
symptoms disappeared.
Table 1 Patients’ characteristics and cardiovascular changes
Characteristics All patients (n = 300) Female (n = 41) Male (n = 259) p value
Mean (SD) age (years) 51 (16) 57 (18) 51 (16) 0.016
Mean (SD) time after SCI (years) 10 (12) 6 (10) 11 (12) 0.019
Stage of SCIa
Acute vs. chronic, no. (%) 68 (23) vs. 232 (7) 16 (39) vs. 25 (61) 52 (20) vs. 207 (80) 0.007
Type of plegia
Tetraplegic vs. paraplegic, no. (%) 98 (33) vs. 202 (67) 11 (27) vs. 30 (73) 87 (45) vs. 172 (65) 0.391
Completeness of lesion (AIS)
Complete (AIS A) vs. incomplete (AIS B-D), no. (%) 120 (40) vs. 180 (60) 9 (22) vs. 32 (78) 111 (43) vs. 148 (57) 0.011
Motor complete (AIS A–B) vs. incomplete
(AIS C–D), no. (%)
170 (57) vs. 130 (43) 15 (37) vs. 26 (63) 155 (60) vs. 104 (40) 0.005
AIS A, no. (%) 120 (40) 9 (22) 111 (43)
AIS B, no. (%) 50 (17) 6 (15) 44 (17)
AIS C, no. (%) 45 (15) 9 (22) 36 (14)
AIS D, no. (%) 85 (28) 17 (41) 68 (26)
Lesion level
At or above T6 vs. below T6, No. (%) 166 (55) vs. 134 (45) 16 (39) vs. 25 (61) 150 (58) vs. 109 (42) 0.024
Cervical, no. (%) 98 (33) 11 (27) 87 (33)
Thoracic, no. (%) 172 (57) 20 (49) 152 (59)
Lumbar (L1–L2), no. (%) 30 (10) 10 (24) 20 (8)
Start of UDIb
Blood pressure
Mean (SD) systolic (mmHg) 127 (23) 123 (24) 127 (23) 0.237
Mean (SD) diastolic (mmHg) 76 (13) 71 (15) 76 (13) 0.010
Mean (SD) heart rate (bpm) 75 (15) 76 (14) 75 (16) 0.956
Cardiovascular change (Δ) during UDIb
Blood pressure
Mean (SD) systolic (mmHg) 42 (34) 38 (22) 43 (35) 0.384
Mean (SD) diastolic (mmHg) 17 (14) 18 (12) 17 (14) 0.697
Mean (SD) heart rate (bpm) –8 (14) –5 (10) –8 (15) 0.086
Presence of NDOb
Yes vs. No, no. (%) 249 (83) vs. 51 (17) 34 (83) vs. 7 (17) 215 (83) vs. 44 (17) 0.989
Statistically significant differences (p<0.05) between female and male patients are highlighted in bold
All values are presented as mean (SD) or number of patients (%)
aSCI defined as “acute” upon 300 days since injury and “chronic” after 300 days according to the European Multicenter Study about Spinal Cord Injury
(EMSCI, www.emsci.org)
bIndicating the worse of two same session UDIs
AIS American Spinal Injury Association (ASIA) Impairment Scale, NDO neurogenic detrusor overactivity, SCI spinal cord injury, SD standard deviation,
UDI urodynamic investigation
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Logistic regression analyses (Table 2) revealed that the le-
sion level, i.e., T6 or above vs. T7 or below, as well as the
presence of neurogenic detrusor overactivity (NDO) pre-
dicted AD during UDI. Further stratification by lesion
level showed a significantly increasing odds of AD with
higher lesion levels. When comparing patients with NDO
and without NDO, statistically significant increases in SBP
and DBP were observed, while changes in HR did not sig-
nificantly differ between both groups (Fig. 2).
Differences between patients with and without
autonomic dysreflexia
When comparing patients with AD and without AD, sta-
tistically significant differences in SBP, DBP, and HR
were observed (Table 3). Remarkably, almost one third
(65/204, 32%) of the patients with AD had a lesion
below T6.
Characteristics of spinal cord injury affect cardiovascular
changes in patients with autonomic dysreflexia
Exploring cardiovascular changes during UDI within the
group of patients with AD, we found several significant
differences related to SCI severity, i.e., the level and the
completeness of the lesion, and the presence of clinical
symptoms. Specifically, patients with cervical lesions ex-
perienced a significantly higher increase in SBP during
UDI compared to those with a thoracic and lumbar le-
sion (Additional file 1). Patients with lesions at T6 or
above showed a significantly higher increase in SBP and
a greater decrease in HR compared to those with a le-
sion at T7 or below (Fig. 3). When stratifying patients
with AD according to the AIS, significantly different
changes in HR were discovered between AIS A and AIS
C, AIS A and AIS D, and AIS B and AIS D (Additional
file 1). Patients suffering from a complete lesion (AIS A)
compared to those with an incomplete lesion (AIS B–
D) showed a significantly greater decrease in HR
(Additional file 1). Patients with a motor complete
lesion (AIS A–B) compared to those with a motor
incomplete lesion (AIS C–D) had a significantly
higher increase in SBP and a greater decrease in HR
(Additional file 1). Patients with symptomatic com-
pared to asymptomatic AD demonstrated a signifi-
cantly higher increase in SBP and DBP as well as a
greater decrease in HR (Fig. 4). No significant cardio-
vascular changes were found for AD patients with
acute compared to those with chronic suprasacral SCI
(Additional file 1).
Discussion
In this prospective cohort study including 300 pa-
tients, we found a high incidence of AD in about two
thirds of our patients with NLUTD due to suprasacral
SCI. In addition, we identified the level of SCI as well
as the presence of NDO as independent significant
predictors to experience AD during UDI. Importantly,
almost one third of our patients with AD had a lesion
level below T6.
A high number of physicians and other healthcare pro-
fessionals may not be aware of AD, unless their patient
population includes individuals with SCI [26]. Thus, the
lack of experience with AD-related SBP changes might
lead to misdiagnosed AD and even acceptance of the po-
tential risk of life-threatening complications during UDI.
Providing evidence on what constitutes an increased risk
for experiencing AD during UDI, i.e., predictors, could
lead to a safer way to perform UDI in this cohort. Most
importantly, education regarding AD, i.e., knowledge
transfer to physicians, other health professionals, care-
givers, and especially patients and family members is
crucial to raise awareness of AD so that AD-related
complications during UDI and in everyday life (including
emergency room admissions for “not feeling right” or
urinary tract symptoms) can be minimized or prevented
at best.
In contrast to episodic BP measurement, which has
often been used to record AD during UDI [27–29], con-
tinuous CVM provides a more accurate observation, as
it allows one to detect short episodes of AD. The “beat-
to-beat” technique allows the Finometer (via finger
photoplethysmography) to monitor cardiovascular
changes of SBP, DBP, and HR continuously and accur-
ately according to the Association for the Advancement
of Medical Instrumentation. Furthermore, the British
Hypertension Society has recommended the Finometer
for measurements in the clinical set-up and for research
purposes. In line with Liu et al. [9] and our previous
study [16], we used continuous CVM to document SBP,
DBP, and HR, i.e., “beat-to-beat” recordings, throughout
Fig. 1 Characteristics of clinical symptoms related to autonomic
dysreflexia (AD) during urodynamic investigation. In 75 patients with
symptomatic AD, 152 counts of clinical symptoms were recorded.
Headache with 33 counts was the most frequent symptom. The
remaining 119 counts included feeling uncomfortable (31), spasticity
(27), sweating (23), general pain (21), piloerection (9), flushing and/or
feeling warm/hot (5), chest pain or discomfort (2), and dyspnea (1)
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the entire investigation to immediately reveal AD. In
fact, AD was detected during UDI in more than two
thirds (204/300) of our patients. In contrast, previous lit-
erature measuring BP episodically reported incidence of
AD between 37 and 43%. This lower incidence of AD
might be attributed to intermittent instead of continuous
CVM, as the former is likely to miss short-term episodes
of AD [27–29]. Evidence for this hypothesis is given, as
we recently found a similarly high incidence of AD
(73%) in women with NLUTD due to suprasacral SCI
[16]. Thus, AD during UDI in individuals with SCI
seems to be generally underestimated, and this might
put our patients at relevant risk if AD is not detected
and appropriately managed.
Sympathetic pre-ganglionic neurons (SPNs) are regarded
as the pivotal spinal neurons for central cardiovascular con-
trol [30]. It is commonly believed that AD occurs in patients
with SCI at or above T6 [31, 32], and most studies have only
presented data in this selected cohort [9, 27, 29, 33].
However, AD can also occur in patients with a lesion level
Table 2 Odds ratios for autonomic dysreflexia during urodynamics
Variable Unadjusted OR (95% CI) p value Adjusted OR (95% CI) p value
Sex
Malea 1 1
Female 2.1 (1.0–5.1) 0.070 2.0 (0.9–4.9) 0.101
Stage of SCIb
Acute 1.2 (0.7–2.1) 0.600 0.8 (0.4–1.7) 0.622
Chronica 1 1
AIS
A 0.9 (0.5–1.6) 0.719 1.4 (0.7–2.9) 0.700
B 1.2 (0.6–2.6) 0.646 1.7 (0.7–4.3) 0.360
C 1.0 (0.5–2.3) 0.939 1.2 (0.5–2.9) 0.850
Da 1 1
Complete vs. incomplete SCI
AIS A–B 0.9 (0.5–1.4) 0.510 1.1 (0.7–2.0) 0.657
AIS C–Da 1 1
Motor complete vs. incomplete SCI
AIS A 1.0 (0.6 – 1.6) 0.880 1.4 (0.8 – 2.6) 0.250
AIS B-Da 1 1
Lesion level, cutoff at T6
At or above T6 5.5 (3.2–9.4) < 0.001 6.6 (3.8–11.7) < 0.001
T7 and belowa 1 1
Lesion level, distributions above T7
C1–C4 13.9 (5.2–48.8) < 0.001 16.2 (5.9–57.9) < 0.001
C5–C8 8.5 (3.5–23.8) < 0.001 12.2 (4.9–35.8) < 0.001
T1–T3 4.3 (1.8–11.7) 0.002 5.2 (2.1–14.5) 0.001
T4–T6 2.4 (1.3–4.7) 0.007 2.6 (1.3–5.2) 0.006
T7 and belowa 1 1
Presence of NDO during UDIc
Yes 2.7 (1.4–4.9) 0.002 2.2 (1.1–4.5) 0.030
Noa 1 1
Statistically significant differences (p<0.05) for the categorical variables against its own reference category are highlighted in bold
All values are presented as OR (95% CI)
Bivariate logistic regression analysis between AD and each categorical variable resulted in crude OR. Multivariate logistic regression analysis between AD and all
categorical variables including age (as a continuous variable) in one model resulted in adjusted OR
aReference category
bSCI defined as “acute” upon 300 days since injury and “chronic” after 300 days according to the European Multicenter Study about Spinal Cord Injury
(EMSCI, www.emsci.org)
cIndicating the worse of two same session UDIs
AD autonomic dysreflexia, AIS American Spinal Injury Association (ASIA) Impairment Scale, C cervical, CI confidence interval, NDO neurogenic detrusor overactivity,
OR odds ratio, SCI spinal cord injury, T thoracic, UDI urodynamic investigation
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below T6, as the sympathetic outflow originates from T1 to
L2 [34] and supplies various regions, such as the heart (T1–
T5) and urinary bladder (L1–L2) [35]. Thus, similar to
Huang et al. [28], we also included patients with SCI below
T6, and about one third of patients with AD in our study
had a lesion below T6. The sympathetic postganglionic neu-
rons, excited by SPNs, synapse with target organs, such as
the heart and blood vessels, and hence are responsible for
the innervation of the splanchnic vascular bed [32]. The
higher the level of injury, the more SPNs are likely to be in-
dependent of central inhibition. Therefore, a growing num-
ber of independent SPNs receiving afferent input from below
the level of injury could provide the critical mass of vasocon-
striction needed to elevate the SBP accordingly [31]. To pro-
vide further evidence on the impact of lesion level on
cardiovascular changes, increase in SBP from baseline in pa-
tients experiencing AD during UDI was highest in those with
a cervical injury, followed by those with a thoracic and lum-
bar injury, respectively. In patients with a lesion below T6, it
is thought that either sympathetic innervation of vascular
structures remains sufficiently under supraspinal sympathetic
control [36], or the extent of disconnected vascular areas is
reduced, leading to a normal inhibitory response to
baroreceptor-mediated reflexes to maintain homeostasis.
AD can also be asymptomatic, known as silent AD
[29, 33]. Remarkably, 63% (129/204) of our patients with
AD were asymptomatic. This condition can be very haz-
ardous, because the discrepancy between cardiovascular
changes and clinical symptoms might be misunderstood
by physicians and therefore assigned incorrectly to other
causes, which could lead to life-threatening situations.
The group of 75 patients with symptomatic AD (37%)
had significantly greater changes in all three cardiovas-
cular domains, i.e., SPB, DBP, and HR, and consisted of
more patients with a lesion level at or above T6 and
complete lesions (AIS A) compared to those with
asymptomatic AD.
Considering the distribution of the lesion level, i.e., at
or above T6 vs. below T6, more patients who were
asymptomatic had a lesion below T6. While preserved
central control of SPNs allows inhibitory descending sig-
nals to counterattack the vasoconstriction, individuals
with a lesion above T6 are lacking central control of
SPNs that innervate the heart (T1–T5). The higher the
lesion above T6, the more likely a patient will show a
slowing down of the heartbeat, potentially result in
bradycardia. This reflects the parasympathetic effort to
respond to the sudden SBP increase in reducing the
heart stroke volume through the vagal nerve. This may
ultimately result in a deterioration of the patient’s
condition.
In line with the literature [37], our AD patients with
an AIS A lesion demonstrated a significantly greater de-
crease in HR than those with an AIS B–D lesion, indi-
cating that the greater the extent of the injury, i.e., the
fewer efferent fibers are spared to uphold central
Fig. 2 Cardiovascular parameters during urodynamic investigation by presence of neurogenic detrusor overactivity. Cardiovascular changes in (a)
SBP, (b) DBP, and (c) HR in SCI patients who have either presented NDO (right side in dark blue) or not (left side in Maya blue). At the start of UDI,
cardiovascular parameters were not significantly different between both groups. In patients with NDO, cardiovascular changes in SBP (44, 95% CI
40.2–48.6 vs. 30, 95% CI 21.1–39.6 mmHg, p = 0.007) and DBP (18, 95% CI 16.3–19.8 vs. 13, 95% CI 9.3–16.6 mmHg, p = 0.016) during UDI were
significantly different compared to patients without NDO. Changes in HR (–8, 95% CI –10.0 to –6.4 vs. −4, 95% CI –7.7 to –0.4) did not
significantly (p = 0.06) differ between both groups. Each circle represents one patient’s cardiovascular changes during UDI. Error bars represent
mean and the 95% CI of cardiovascular changes; i.e., the worse out of two same session UDIs was used. BPM beats per minute, CI confidence
interval, DBP diastolic blood pressure, HR heart rate, NDO neurogenic detrusor overactivity, SBP systolic blood pressure, SCI spinal cord injury, UDI
urodynamic investigation
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sympathetic control of the heart, the greater the influ-
ence on HR by the parasympathetic nervous system. In
contrast to our observation, Giannantoni et al. [27] re-
ported that AD did not correlate with the completeness
of a lesion. These discrepancies might be attributed to
differences in cardiovascular assessment, individual
number, and characteristics of SCI, hampering a mean-
ingful comparison but warranting further investigation
of these issues. It should be acknowledged that the ex-
tent of an SCI reaches beyond the sensorimotor impair-
ment. Whether an SCI is autonomic complete, i.e.,
supraspinal sympathetic control is entirely lost, or not
seems to have a significant influence on blood pressure
and heart rate. According to the review by West et al.
[38] in patients with chronic SCI, the autonomic
completeness of SCI is more strongly related to
Table 3 Baseline characteristics and cardiovascular changes: differences between patients with and without AD
Characteristics No AD (n = 96) AD (n = 204) p value
Sex
Male vs. female, no. (%) 88 (92) vs. 8 (8) 171 (84) vs. 33 (16) 0.065
Mean (SD) age (years) 49 (15) 53 (16) 0.044
Mean (SD) time after SCI (years) 10 (10) 11 (12) 0.706
Stage of SCIa
Acute vs. chronic, no. (%) 20 (21) vs. 76 (79) 48 (23) vs. 156 (77) 0.603
Type of plegia
Tetraplegic vs. paraplegic, no. (%) 10 (10) vs. 86 (90) 88 (43) vs. 116 (57) < 0.001
Completeness of lesion (AIS)
Complete (AIS A) vs. incomplete (AIS B–D), no. (%) 41 (43) vs. 55 (57) 79 (39) vs. 125 (61) 0.511
Motor complete (AIS A–B) vs. incomplete
(AIS C–D), no. (%)
55 (57) vs. 41 (43) 115 (56) vs. 89 (44) 0.881
AIS A, no. (%) 41 (43) 79 (39)
AIS B, no. (%) 14 (15) 36 (18)
AIS C, no. (%) 14 (15) 31 (15)
AIS D, no. (%) 27 (28) 58 (28)
Lesion level
At or above T6 vs. below T6, no. (%) 27 (28) vs. 69 (72) 139 (68) vs. 65 (32) < 0.001
Cervical, no. (%) 10 (10) 88 (43)
Thoracic, no. (%) 72 (75) 100 (49)
Lumbar (L1–L2), no. (%) 14 (15) 16 (8)
Start of UDIb
Blood pressure
Mean (SD) systolic (mmHg) 133 (22) 124 (23) 0.001
Mean (SD) diastolic (mmHg) 79 (15) 74 (12) 0.001
Mean (SD) heart rate (bpm) 74 (15) 76 (16) 0.458
Cardiovascular change (Δ) during UDIb
Blood pressure
Mean (SD) systolic (mmHg) 7 (8) 58 (29) < 0.001
Mean (SD) diastolic (mmHg) 5 (6) 23 (13) < 0.001
Mean (SD) heart rate (bpm) 1 (8) –11 (15) < 0.001
Presence of NDOb
Yes vs. No, no. (%) 70 (73) vs. 26 (27) 179 (88) vs. 25 (12) 0.001
Statistically significant differences (p<0.05) between patients with and without autonomic dysreflexia are highlighted in bold
All values are presented as mean (SD) or number of patients (%)
aSCI defined as “acute” upon 300 days since injury and “chronic” after 300 days according to the European Multicenter Study about Spinal Cord Injury
(EMSCI, www.emsci.org)
bIndicating the worse of two same session UDIs
AD autonomic dysreflexia, AIS American Spinal Injury Association (ASIA) Impairment Scale, NDO neurogenic detrusor overactivity, SCI spinal cord injury,
SD standard deviation, UDI urodynamic investigation
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Fig. 3 Cardiovascular changes during urodynamic investigation by lesion level (cutoff T6). Cardiovascular changes in (a) SBP, (b) DBP, and (c) HR
in SCI patients with AD who have either sustained a SCI at T6 or above (left side in Maya blue) or at T7 or below (right side in dark blue). At the
start of UDI, cardiovascular parameters were not significantly different between both groups. In patients with a SCI at T6 or above, cardiovascular
changes in SBP (65, 95% CI 59.7–69.7 vs. 45, 95% CI 39.6–49.5 mmHg) and HR (−14, 95% CI –16.6 to –11.4 vs. −6, 95% CI –8.2 to –2.9 bpm) were
significantly different (p < 0.001) compared to those of remaining patients. Each circle represents one patient’s cardiovascular changes during UDI.
Error bars represent mean and the 95% CI of cardiovascular changes; i.e., the worse out of two same session UDIs were used. AD autonomic
dysreflexia, BPM beats per minute, CI confidence interval, DBP diastolic blood pressure, HR heart rate, SBP systolic blood pressure, SCI spinal cord
injury, T thoracic, UDI urodynamic investigation
Fig. 4 Cardiovascular parameters during urodynamic investigation by symptomatic vs. asymptomatic AD. Cardiovascular changes in (a) SBP, (b)
DBP, and (c) HR in SCI patients with AD who have either presented symptoms (right side in dark blue) or not (left side in Maya blue). At the start of
UDI, cardiovascular parameters were not significantly different between both groups. In patients with symptomatic AD, cardiovascular changes in
SBP (72, 95% CI 67.6–76.7 vs. 50, 95% CI 45.8–54.8 mmHg), DBP (27, 95% CI 25.0–29.1 vs. 21, 95% CI 18.5–22.6 mmHg) and HR (−19, 95% CI –21.6
to –16.7 vs. −7, 95% CI –9.0 to –4.3) during UDI were significantly different (p < 0.001) compared to those of remaining patients. Each circle
represents one patient’s cardiovascular changes during UDI. Error bars represent mean and the 95% CI of cardiovascular changes; i.e., the worse
out of two same session UDIs were used. AD autonomic dysreflexia, BPM beats per minute, CI confidence interval, DBP diastolic blood pressure,
HR heart rate, SBP systolic blood pressure, SCI spinal cord injury, UDI urodynamic investigation
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cardiovascular function than neurological completeness
of injury. However, we do not have enough data from all
of our patients to investigate the effect of autonomic
completeness on the incidence of AD and cardiovascular
changes during UDI.
In line with Liu et al. [15], we found significantly dif-
ferent cardiovascular changes in patients with NDO
compared to those without. Being considered a major
cause to trigger AD [15] and leading to significant in-
creases in arterial pressure [39], NDO seems to pose a
significant health risk to patients with SCI. This is clinic-
ally relevant, as most patients with SCI suffer from NDO
[40]. As a result of NDO, repeatedly increased intravesi-
cal pressures can lead to morphological changes of the
urinary tract and increased risk of upper urinary tract
complications in the long term [4, 41]. The latter com-
prise vesico-uretero-renal reflux, hydronephrosis, im-
pairment of renal functions, or at worst renal failure [4].
Treatment of NDO, i.e., with antimuscarinic drugs and
intradetrusor onabotulinumtoxinA injections, results in
reduction of intravesical pressure, improves quality of
life, and has been successfully implemented into clinical
practice and guidelines [3]. Given the potential of NDO
to elicit AD, successful treatment of NDO could also
have a positive effect on AD incidence and extent of re-
lated cardiovascular changes. In line with this hypoth-
esis, Fougere et al. [42] provided evidence of effectively
reducing the frequency and severity of AD after intrade-
trusor onabotulinumtoxinA injections in patients with
SCI. By improving LUT function and concurrently redu-
cing cardiovascular responses to LUT stimuli, treatment
of NDO appears to have the capacity to lower the risk
for AD-related long-term complications.
Although to the best of our knowledge this is the lar-
gest prospective cohort study investigating AD using
continuous cardiovascular changes in patients with
suprasacral SCI suffering from NLUTD, some limita-
tions should be addressed. Common conditions such as
urinary tract infections, medications, and fluctuations of
the neurological state can influence lower urinary tract
function and consequently UDI and CVM parameters.
Furthermore, as we only included those patients with
SCI who are affected by NLUTD, which represents most
SCI patients, it is difficult to say whether our results
could also be extrapolated to SCI patients without
NLUTD. Moreover, demonstrating the impact of SCI le-
sion level, completeness, and symptomatology of AD on
cardiovascular changes during UDI, it would be of great
interest to continuously monitor cardiovascular parame-
ters during long-term ambulatory UDI to further assess
the cardiovascular risk profile in patients with SCI.
Despite these limitations, our study is the first to pro-
vide evidence that AD during UDI is predictable by le-
sion level and presence of NDO. Our results clearly
underline the importance of continuous CVM during
UDI in all patients with suprasacral SCI and emphasize
the relevance of proactive NDO treatment. In this way,
AD can be detected earlier and more frequently, which
subsequently could lead to fewer episodes of AD-related
complications during diagnostic assessment or at best
none. To further protect patients with SCI, continuous
CVM should also be considered as standard surveillance
during other diagnostic interventions such as cystoscopy
[9] and sperm retrieval [43].
Conclusions
Considering all potential health risks associated with
AD, such as seizures, stroke, retinal bleeding, or even
death, we highly recommend continuous CVM during
UDI in all patients with suprasacral SCI, since focus-
ing on lesions at T6 or above would result in missing
a relevant percentage of patients with AD. However,
particular emphasis should be given to individuals
with cervical lesions, as they are at highest risk for
AD during UDI.
Given our previous experiences [16, 21], we propose
performing same session repeat UDI with continuous
CVM, which allows one to provide the treating urologist
with more precise information on the extent of NLUTD
and cardiovascular changes during UDI.
Moreover, we advise considering appropriate treat-
ment of NDO, not only to protect the upper urinary
tract from potential long-term damage, but also to im-
prove quality of life and decrease the risk of AD. Follow-
ing our recommendations will also allow for revealing
findings of cardiovascular risk factors in patients with si-
lent AD and might subsequently reduce the risk of po-
tentially life-threating complications related to sudden
hypertension during AD.
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